KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Operating Expenses (2016 - 2025)

Thermo Fisher Scientific's Operating Expenses history spans 17 years, with the latest figure at $10.0 billion for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses rose 6.19% year-over-year to $10.0 billion, compared with a TTM value of $36.8 billion through Dec 2025, up 3.57%, and an annual FY2025 reading of $36.8 billion, up 3.57% over the prior year.
  • Operating Expenses for Q4 2025 was $10.0 billion at Thermo Fisher Scientific, up from $9.2 billion in the prior quarter.
  • The five-year high for Operating Expenses was $10.0 billion in Q4 2025, with the low at $6.9 billion in Q2 2021.
  • Average Operating Expenses over 5 years is $8.7 billion, with a median of $9.0 billion recorded in 2022.
  • Year-over-year, Operating Expenses surged 31.21% in 2022 and then fell 5.81% in 2023.
  • Tracing TMO's Operating Expenses over 5 years: stood at $8.2 billion in 2021, then increased by 17.45% to $9.6 billion in 2022, then dropped by 5.81% to $9.0 billion in 2023, then rose by 3.84% to $9.4 billion in 2024, then grew by 6.19% to $10.0 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Operating Expenses are $10.0 billion (Q4 2025), $9.2 billion (Q3 2025), and $9.0 billion (Q2 2025).